Publicacións nas que colabora con María Pérez Mato (29)

2024

  1. Pharmacological preclinical comparison of tenecteplase and alteplase for the treatment of acute stroke

    Journal of Cerebral Blood Flow and Metabolism, Vol. 44, Núm. 8, pp. 1306-1318

  2. Precision Medicine for Blood Glutamate Grabbing in Ischemic Stroke

    International Journal of Molecular Sciences, Vol. 25, Núm. 12

  3. Preclinical validation of human recombinant glutamate-oxaloacetate transaminase for the treatment of acute ischemic stroke

    iScience, Vol. 27, Núm. 11

2023

  1. Perfusion-weighted software written in Python for DSC-MRI analysis

    Frontiers in Neuroinformatics, Vol. 17

2022

  1. Associations between RNA-Binding Motif Protein 3, Fibroblast Growth Factor 21, and Clinical Outcome in Patients with Stroke

    Journal of Clinical Medicine, Vol. 11, Núm. 4

  2. Fibrin-Targeted Nanoparticles for Finding, Visualizing and Characterizing Blood Clots in Acute Ischemic Stroke

    Pharmaceutics, Vol. 14, Núm. 10

  3. Stress Granules and Acute Ischemic Stroke: Beyond mRNA Translation

    International Journal of Molecular Sciences, Vol. 23, Núm. 7

  4. Surrogate biomarkers of outcome for wake-up ischemic stroke

    BMC Neurology, Vol. 22, Núm. 1

2021

  1. Characterization of a temporal profile of biomarkers as an index for ischemic stroke onset definition

    Journal of Clinical Medicine, Vol. 10, Núm. 14

  2. Inhibition of endogenous blood glutamate oxaloacetate transaminase enhances the ischemic damage

    Translational Research, Vol. 230, pp. 68-81

  3. sTWEAK as Predictor of Stroke Recurrence in Ischemic Stroke Patients Treated With Reperfusion Therapies

    Frontiers in Neurology, Vol. 12

2020

  1. Cold stress protein RBM3 responds to hypothermia and is associated with good stroke outcome

    Brain Communications, Vol. 2, Núm. 2

  2. Sustained blood glutamate scavenging enhances protection in ischemic stroke

    Communications Biology, Vol. 3, Núm. 1

  3. Temperature-induced changes in reperfused stroke: Inflammatory and thrombolytic biomarkers

    Journal of Clinical Medicine, Vol. 9, Núm. 7, pp. 1-12

  4. The presence of leukoaraiosis enhances the association between sTWEAK and hemorrhagic transformation

    Annals of Clinical and Translational Neurology, Vol. 7, Núm. 11, pp. 2103-2114

2014

  1. Human recombinant glutamate oxaloacetate transaminase 1 (GOT1) supplemented with oxaloacetate induces a protective effect after cerebral ischemia

    Cell Death and Disease, Vol. 5, Núm. 1

2013

  1. Glutamate oxaloacetate transaminase: A new key in the dysregulation of glutamate in migraine patients

    Cephalalgia, Vol. 33, Núm. 14, pp. 1148-1154

  2. Hyperthermia in human ischemic and hemorrhagic stroke: Similar outcome, different mechanisms

    PLoS ONE, Vol. 8, Núm. 11

2012

  1. Glutamate Excitoxicity Is the Key Molecular Mechanism Which Is Influenced by Body Temperature during the Acute Phase of Brain Stroke

    PLoS ONE, Vol. 7, Núm. 8

  2. Increased levels of circulating endothelial progenitor cells in patients with ischaemic stroke treated with statins during acute phase

    European Journal of Neurology, Vol. 19, Núm. 12, pp. 1539-1546